Poole Jonathan bought ACAD
March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 4,218 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,218
Price
$0.00
Total value
N/A
InsiderPoole Jonathan
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 20, 2026
Shares owned after4,218
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.; The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant.